Literature DB >> 1196582

Tumour-associated surface antigen(s) in human astrocytomas.

H B Coakham, M S Lakshmi.   

Abstract

The cytotoxic properties of a hetero-antiserum have been used to demonstrate surface antigen(s) common to seven human astrocytomas. This has been designated human astrocytoma-associated antigen (HAAA). Tissue cultures of astrocytomas were prepared. A rabbit antiserum was raised to one of these and its antibody activity on the original tumour cells assayed by dye exclusion cytotoxicity testing. After repeated absorption with associated antigen(s). In a series of absorption experiments, HAAA was detected in six other human astrocytoma cultures, but not found in a series of other human tumours and tissues tested. Homogenates of two original astrocytomas absorbed out HAAA activity in a similar way indicating the presence of the antigen(s) in vivo. The significance of this HAAA is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1196582

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  8 in total

Review 1.  The immunobiology of human gliomas.

Authors:  V Piguet; A C Diserens; S Carrel; J P Mach; N de Tribolet
Journal:  Springer Semin Immunopathol       Date:  1985

2.  The biology of human brain tumours.

Authors:  P Kumar
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

Review 3.  Immunobiologic aspects of the brain and human gliomas. A review.

Authors:  C J Wikstrand; D D Bigner
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

4.  Immunological aspects of gliomas.

Authors:  A Ridley
Journal:  Proc R Soc Med       Date:  1977-12

5.  Intratumoral autologous mononuclear cells in the treatment of recurrent glioblastoma multiforme. A phase 1 (toxicity) study.

Authors:  P Steinbok; J P Thomas; L Grossman; C L Dolman
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

6.  Are human DNA tumour viruses involved in the pathogenesis of human neurogenic tumors?

Authors:  H Ibelgaufts
Journal:  Neurosurg Rev       Date:  1982       Impact factor: 3.042

7.  The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.

Authors:  M L Apuzzo; K M Sheikh; M H Weiss; J S Heiden; T Kurze
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

8.  Electron-microscopic visualization of binding of antibodies from sera of glioma patients on cultured glioma cells.

Authors:  G M Lauro; C Solheid; L Medolago-Albani; N Di Lorenzo; B Guidetti
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.